- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Emphasizing Access
With the average cost of an emergency room visit hovering at $1,200, funneling patients through the ER is not an effective way to manage chronic health conditions. Those who lack medical insurance aren't the only subgroup using the ER as a doctor's office.
With the average cost of an emergency room visit hovering at $1,200, funneling patients through the ER is not an effective way to manage chronic health conditions. Those who lack medical insurance aren't the only subgroup using the ER as a doctor's office.
Many folks across the country, insured, uninsured and underinsured, are forced to rely on emergency departments because they lack convenient access to physicians with specialized expertise.
Persistent health problems such as asthma, diabetes and hypertension are just a few of the conditions that require periodic checkups with medical specialists. Unfortunately, in some neighborhoods, specialists are in short supply. This is especially hard on the elderly, on people who lack access to reliable transportation, and on many others who don't have the luxury of requesting sick leave in order to travel long distances.
Read the full story here: http://bit.ly/KNKYKB
Source: Modern Healthcare
AI Meets Medicare: Inside CMS’s WISeR Model With Sanjay Doddamani, MD, MBA, Part 2
August 5th 2025In this second part of his interview with The American Journal of Managed Care®, Sanjay Doddamani, MD, MBA, a former senior advisor to CMMI and founder and CEO of Guidehealth, continues a dialogue on the future of value-based care and the promise—and limits—of AI-enabled innovation, reflecting on challenges like rising Medicare costs and patients’ growing financial burdens.
Read More
Trump Directs Pharma Companies on Cutting Drug Prices Under Most-Favored-Nation Order
July 31st 2025President Donald Trump has sent letters to pharmaceutical companies, aiming to compel them to lower drug prices in the US to match the lowest prices offered in other developed nations, a move that could significantly reduce costs and disrupt the current system of pharmacy benefit managers.
Read More
